Artificial intelligence (AI) could hold the key to identifying people at risk of pancreatic cancer early, allowing them to start potentially life-saving treatment more quickly.
Roche has doubled down on a partnership with UK biotech Oncimmune looking at how autoantibodies can affect patients’ clinical response to cancer immunotherapies.
Researchers in the UK say they developed an artificial intelligence-based computer model that can reliably detect COVID-19 in X-rays, which could help assist diagnoses when cor